Heritage Insurance Holdings, Inc. current report, 07 May 2018

Business Context and Reporting Period

Company: Heritage Insurance Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 7, 2018
Reporting Period: Fiscal quarter ended March 31, 2018

This filing serves to announce the issuance of a press release detailing the Company's financial results for the first quarter of 2018. The specific financial data is contained within the attached press release (Exhibit 99.1) and is not explicitly detailed in the body of this Form 8-K.

Key Financial Metrics

The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the attached press release (Exhibit 99.1) but are not present in the filing text itself.

Material Changes

No material changes versus the prior comparable period are described in the text of this filing. The document solely references the announcement of results without providing comparative analysis or specific variance data.

Guidance, Outlook, and Risks

Management Commentary: The filing notes that the Chairman and Chief Executive Officer, Bruce Lucas, authorized the report to disseminate the Q1 2018 results.
Legal Status of Information: The information furnished under Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Risks and Contingencies: No specific risks, contingencies, or unusual items are detailed in this summary text.

Investor Verification Checklist

  • Review the attached press release (Exhibit 99.1) for specific Q1 2018 financial figures (revenue, net income, EPS).
  • Verify the Company's status as an emerging growth company (indicated as "No" in the filing).
  • Confirm that the financial data in the press release is not automatically incorporated by reference into other SEC filings.
  • Check subsequent filings for detailed management discussion and analysis (MD&A) regarding the reported results.